NCT05865535 2026-01-08A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaAVEO Pharmaceuticals, Inc.Phase 1 Recruiting30 enrolled
NCT06898255 2025-06-05A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or CachexiaGenfleet Therapeutics (Shanghai) Inc.Phase 1 Recruiting36 enrolled
NCT04803305 2024-01-12Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaPfizerPhase 1 Completed18 enrolled 14 charts
NCT04299048 2023-12-14Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.PfizerPhase 1 Completed11 enrolled 13 charts